Introduction

Clinical Trials for Stargardt’s

Clinical Trials for Stargardt’s

Clinical Trials for Stargardt's

Our friends at the Retina Clinic London, are dedicated to advancing retinal care through cutting-edge research and clinical innovation. They actively collaborate with the pharmaceutical industry to bring the latest treatments to patients, ensuring that individuals have greater choice in their ophthalmic care.

The Retina Clinic’s clinical trials provide patients with early access to pioneering therapies, often years before they become widely available. Led by Professor Stanga and his team of world-renowned retinal specialists, they focus on developing new diagnostic techniques, advanced treatments, and surgical innovations to improve vision outcomes.

We are delighted to announce that they have become the first site for a new clinical trial in Stargardt’s. This is a Phase 1 industry-sponsored gene therapy study.

Sebastian Stanga sits in a medical office next to advanced eye imaging equipment. He is wearing a dark navy suit, a white shirt, and a patterned reddish-brown tie. He is looking toward a large, white medical device labeled "Intalight" and "VG200D," which is used for ophthalmic imaging. On the desk next to the device is a computer monitor displaying a black-and-white image of retinal vasculature. A second monitor in the background shows a standard computer desktop wallpaper. The room has light green walls and a professional clinical appearance.

What is Stargardt Disease?

For those unfamiliar with the condition, Stargardt’s is a rare, inherited condition that affects the macula (the centre of the retina).

  • The Cause: It is linked to gene mutations (like ABCA4 gene), which cause a buildup of waste product called lipofuscin.

  • The Impact: This leads to damage of photoreceptor cells, causing a progressive loss of central, detailed, and colour vision.

  • The Symptoms: While it often starts in childhood with blurry vision or blind spots, peripheral vision typically remains intact.

While there is currently no cure, this new clinical trial offers hope by providing early access to cutting-edge therapies.

For a more in depth breakdown about Stargardt's visit the RNIB wesbite - Click Here.

How This Trial Works for Participants

The Retina Clinic is welcoming patients from across the United Kingdom. To make participation as easy as possible for you and your family:

  • Fully Funded: The trial is free of charge.

  • Travel: All travel expenses are covered for the patient and an accompanying person (including train or taxi travel to London).

  • Stay: If an overnight stay is necessary—for example, for surgery—accommodation can be provided.

Your Safety

All clinical trials conducted at Retina Clinic London have full ethics committee approvals, ensuring patient safety, ethical integrity, and scientific validity. In many of these studies, Professor Paulo Stanga serves as the Chief Investigator at a national level, overseeing the trial’s implementation across multiple sites and playing a key role in the ethics approval process.

Whilst Devon in Sight cannot endorse any specific product or service, we are here to provide you with the information you need to make informed choices. We encourage you to discuss this information with your Health Care Professional.